APOE status and its association to learning and memory performance in middle aged and older Norwegians seeking assessment for memory deficits

Behavioral and Brain Functions

Volumn 3, Issue , 2007, Pages

  Wehling, Eike ^a   Lundervold, Astri J ^a   Standnes, Brit ^c   Gjerstad, Leif ^d   Reinvang, Ivar ^b  

^a UNIVERSITY OF BERGEN   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c Sykehuset Buskerud HF   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E4;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; BRAIN INFARCTION; COGNITIVE DEFECT; CONTROLLED STUDY; DEGENERATIVE DISEASE; DISEASE SEVERITY; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENETIC ASSOCIATION; HETEROZYGOTE; HUMAN; LEARNING DISORDER; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MENTAL DISEASE; MINI MENTAL STATE EXAMINATION; NEUROLOGIC DISEASE; NORWAY; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; TASK PERFORMANCE; VISUAL MEMORY;

EID: 38049143662     PISSN: 17449081     EISSN: None     Source Type: Journal    
DOI: 10.1186/1744-9081-3-57     Document Type: Article

References (60)

1. Lobo A Launer LJ Fratiglioni L Andersen K Di Carlo A Breteler MM Copeland JR Dartigues JF Jagger C Martinez-Lage J Soininen H Hofman A Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic diseases in the elderly research group Neurology 2000, 54:4-9. 10636116
2. Morris JC Storandt M Miller JP McKeel DW Price JL Rubin EH Berg L Mild cognitive impairment represents early-stage Alzheimer disease Arch Neurol 2001, 8:397-405. 10.1001/archneur.58.3.397
3. Petersen RC Mild cognitive impairment as a diagnostic entity J Intern Med 2004, 256:183-194. 10.1111/j.1365-2796.2004.01388.x 15324362
4. Arnaiz E Almkvist O Ivnik RJ Tangalos EG Wahlund LO Winblad B Petersen RC Mild cognitive impairment: A cross-national comparison J Neurol Neurosurg Psychiatry 2004, 75:1275-1280. 10.1136/jnnp.2003.015032 15314114
5. Koivisto K Reinikainen KJ Hanninen T Vanhanen M Helkala EL Mykkanen L Laakso M Pyorala K Riekkinen PJ Prevalence of age-associated memory impairment in a randomly selected population from eastern Finland Neurology 1995, 45:741-747. 7723964
6. Fisk JD Merry HR Rockwood K Variations in case definition affect prevalence but not outcome in mild cognitive impairment Neurology 2003, 61:1179-1184. 14610117
7. Tervo S Kivipelto M Hanninen T Vanhanen M Hallikainen M Mannermaa A Soininen H Incidence and risk factors for mild cognitive impairment: A population-based three-year follow-up study of cognitively healthy elderly subjects Dement Geriatr Cog Disorders 2004, 17:196-203. 10.1159/ 000076356
8. Raber J Huang Y Wesson Ashford J APOE accounts for the vast majority of AD risk and AD pathology Neurobiol Aging 2004, 25:6741-6750. 10.1016/ j.neurobiolaging.2003.12.023
9. Blacker D Haines JL Rodes L Terwedow H Go RC Harrell LE Perry RT Barret SS Chase G Meyers D Albert MS Tanzi R APOE 4 and age at onset of Alzheimer's disease: The NIMH genetics initiative Neurology 1997, 48:139-147. 9008509
10. Farrer LA Cupples LA Haines JL Hyman B Kukull WA Mayeux R Myers RH Pericak-Vance MA Risch N vanDuijn CM Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium JAMA 1997, 278:1349-1356. 10.1001/jama.278.16.1349 9343467
11. Farlow MR He Y Tekin S Xu J Lane R Charles HC Impact of APOE in mild cognitive impairment Neurology 2004, 63:1898-1901. 15557508
12. Smith GE Bohac DL Waring SC Kokmen E Tangalos EG Ivnik RJ Petersen RC Apolipoprotein E genotype influences cognitive 'phenotype' in patients with Alzheimer's disease but not in healthy control subjects Neurology 1998, 50:355-362. 9484353
13. Bondi MW Salmon DP Monsch AU Galasko D Butters N Klauber MR Thal LJ Saitoh T Episodic memory changes are associated with the APOE-epsilon 4 allele in nondemented older adults Neurology 1995, 45:2203-2206. 8848194
14. Bondi MW Salmon DP Galasko D Thomas RG Thal LJ Neuropsychological function and apolipoprotein E genotype in the preclinical detection of Alzheimer's disease Psychol Aging 1999, 14:295-303. 10.1037/ 0882-7974.14.2.295 10403716
15. Mahley RW Weisgraber KH Huang Y Apolipiprotein E4: A causative factor and therapeutic target in neuropathology, including Alzheimer's disease Proc Natl Acad Sci USA 2006, 103:5641-5644. 1458626 16585500 10.1073/ pnas.0600549103
16. Small BJ Rosnick CB Fratiglioni L Backman L Apolipoprotein E and cognitive performance: A meta-analysis Psychol Aging 2004, 19:592-600. 10.1037/0882-7974.19.4.592 15584785
17. Mayeux R Small SA Tang M Tycko B Stern Y Memory performance in healthy elderly without Alzheimer's disease: Effects of time and apolipoprotein-E Neurobiol Aging 2001, 22:683-689. 10.1016/ S0197-4580(01)00223-8 11445269
18. Caselli RJ Reiman EM Osborne D Hentz JG Baxter LC Hernandez JL Alexander GG Longitudinal changes in cognition and behavior in asymptomatic carriers of the APOE ε4 allele Neurology 2004, 62:1990-1995. 15184602
19. Mortensen EL Hogh PA Gender difference in the association between APOE genotype and age-related cognitive decline Neurology 2001, 57:89-95. 11445633
20. Reiman EM Caselli RJ Yun LS Chen K Bandy D Minoshima S Thibodeau SN Osborne D Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E New Engl J Med 1996, 334:752-758. 10.1056/NEJM199603213341202 8592548
21. Bookheimer SY Strojwas MH Cohen MS Saunders AM Pericak-Vance MA Maziotta JC Small GW Pattern of brain activation in people at risk for Alzheimer's disease New Engl J Med 2000, 343:450-456. 10.1056/ NEJM200008173430701 10944562
22. Lind J Persson J Ingvar M Larsson A Cruts M Van Broeckhoven C Adolfsson R Backman L Nilsson LG Petersson KM Nyberg L Reduced functiobnal brain activity response in cognitively intact apolipoprotein E ε4 carriers Brain 2006, 129:1240-1248. 10.1093/brain/awl054 16537568
23. Greenwood PM Parasuraman R Normal genetic variation, cognition, and aging Behav Cogn Neurosci Rev 2003, 2:278-306. 1383745 15006290 10.1177/ 1534582303260641
24. Espeseth T Greenwood P Reinvang I Fjell AM Walhovd KB Westlye LT Wehling E Lundervold AJ Rootwelt H Parasuraman R Interactive effects of APOE and CHRNA4 on attention and white matter volume in healthy middle aged and older adults Cogn Affect Behav Neurosci 2006, 6:31-43. 16869227
25. Gureje O Ogunniyi A Baiyewu O Price B Unverzagt F Evans RM Smith-Gamble V Lane KA Gao S Hall KS Hendrie HC Murrell JR APOE ε4 is not associated with Alzheimer's Disease in elderly Nigerians Ann Neurol 2006, 59:182-185. 10.1002/ana.20694 16278853
26. Gerdes LU The common polymorphism of apolipoprotein E: Geographical aspects and new pathophysiological relations Clin Chem Lab Med 2003, 41:628-631 10.1515/CCLM.2003.094 12812258
27. Berr C Wancata J Ritchie K Prevalence of dementia in the elderly in Europe Eur Neuropsychopharmacol 2005, 15:463-471 10.1016/ j.euroneuro.2005.04.003 15955676
28. Fratiglioni L Launer LJ Andersen K Breteler MED MER Copeland JR Dartigues J-F Lobo A Martinez-Lage J Soininen H Hofman A Incidence of dementia and major subtypes in Europe: A collaborative study Neurology 2000(Suppl 5):S10-S15
29. Welsh KA Butters N Mohs RC Beekly D Edland S Fillenbaum G Heyman A The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery Neurology 1994, 44:609-614 8164812
30. Sundet K Lundervold AJ CVLT-Norsk versjon Sollentuna, Psykologiförlaget AB 2004
31. Folstein MF Folstein SE McHugh PR "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician Journal Psychiatr Res 1995, 12:189-198 10.1016/ 0022-3956(75)90026-6
32. American Psychiatric Association Diagnostic and statistical manual of mental disorders DSM-IV Washington, D.C.: Author 4 1994
33. World Health Organization The ICD-10 Classification of Mental and Behavioral Disorders Geneva: Author 1993
34. World Medical Association Declaration of Helsinki. Recommendations guiding physicians in biomedical research involvinghuman subjects J Med Assoc 1993, 277:925-926
35. Lezak M Howieson DB Loring DW Neuropsychological assessment New York: Oxford University Press 4 1993
36. Wechsler D Wechsler Abbreviated Scales of Intelligence New York: The Psychological Corporation 1999
37. Delis D Kramer J Kaplan E Ober B The California Verbal Learning Test New York: The Psychological Corporation; 1987 3628618
38. Andersen R Verbal and visuo-spatial memory. Two clinical tests administered to a group of normal subjects Scand J Psychol 1976, 17:198-294
39. Osterrieth PA Le test de copie d'une figure complexe Archives de Psychologie 1944, 30:206-356 [transl. Corwin, J, Bylsma, FW. Clinical Neuropsychol 1993, 7: 9-15]
40. Wechsler D Wechsler Adult Intelligence Scale - Revised manual New York: The Psychological Corporation 1981
41. Reitan RM Davidson LA Clinical Neuropsychology: Current Status and Applications Washington, D.C.: Winston & Sons; 1974
42. Jensen AR Rohwer WD The Stroop Color-Word Test: A review Acta Psychologica 1966, 25:36-93 10.1016/0001-6918(66)90004-7 5328883
43. Benton AL Hamsher K Multilingual Aphasia Examination Iowa City: AJA Associates 1989
44. Kaplan EF Goodglass H Weintraub S The Boston Naming Test Philadelphia: Lea & Febinger 2 1989
45. Frisoni GB Scheltens P Galluzzi S Nobili FM Fox NC Robert PH Soininen H Wahlund LO Waldemar G Salmon E Neuroimaging tools to rate regional atrophy, subcortical cerebrovascular disease, and regional cerebral blood flow and metabolism: Consensus paper of the EADC J Neurol Neurosurg Psychiatry 2003, 74:1371-81 10.1136/jnnp.74.10.1371 14570828
46. SPSS SPSS for Windows. [Release 14.0] Chicago, Ill., SPSS, Inc 2006
47. Cohen J A power primer Psychol Bull 1992, 112:155-159 10.1037/ 0033-2909.112.1.155
48. Tierney MC Yao C Kiss A McDowell I Neuropsychological tests accurately predict incident Alzheimer disease after 5 and 10 years Neurology 2005, 64:1853-1859 10.1212/01.WNL.0000163773.21794.0B 15955933
49. Albert MS Moss MB Tanzi R Jones K Preclinical prediction of AD using neuropsychological tests J Int Neuropsychol Soc 2001, 7:631-639 10.1017/ S1355617701755105 11459114
50. Grober E Kawas C Learning and retention in preclinical and early Alzheimer's disease Psychol Aging 1997, 12:183-188 10.1037/ 0882-7974.12.1.183 9100279
51. Chey J Kim JW Cho HY Effects of apolipoprotein E phenotypes on the neuropsychological functions of community-dwelling elderly individual without dementia Neurosci Lett 2000, 289:230-234 10.1016/ S0304-3940(00)01288-X 10961672
52. Cohen RM Small C Lalonde F Friz J Sunderland T Effect of apolipoprotein E genotype on hippocampal volume loss in aging healthy women Neurology 2001, 57:2223-2228 11756601
53. Lautenschlager NT Flicker S Vasikaran S Leedman P Almeida OP Subjective memory complaintes with and without objective memory impairment: Relationship with risk factors for dementia Am J Geriatr Psychiatry 2005, 13:731-734 10.1176/appi.ajgp.13.8.731 16085790
54. Petersen RC Smith GE Waring SC Ivnik RJ Tangalos EG Kokmen E Mild cognitive impairment: Clinical characterization and outcome Arch Neurol 1999, 56:303-308 10.1001/archneur.56.3.303 10190820
55. Devanand DP Pelton GH Zamora D Liu X Tabert MH Goodkind M Scarmeas N Braun I Stern Y Mayeux R Predictive utility of Apolipoprotein E genotype for Alzheimer Disease in outpatients with mild cognitive impairment Arch Neurol 2005, 62:975-980 10.1001/archneur.62.6.975 15956169
56. Palmer BW Boone KB Lesser IM Wohl MA Base rates of impaired neuropsychological test performance among healthy older adults Arch Clin Neuropsychol 1998, 13:503-511 10.1016/S0887-6177(97)00037-1 14590634
57. deRetrou J Wenisch E Chausson C Dray F Faucounau V Rigaud AS Accidental MCI in healthy subjects: A prospective longitudinal study Eur J Neurol 2005, 12:879-885 10.1111/j.1468-1331.2005.01100.x 16241977
58. Caselli RJ Osborne D Reiman EM Hentz JJG Barbieri CJ Saunders AM Hardy J Graff-Radford NR Hall GR Alexander GE Preclinical cognitive decline in late middle-aged asymptomatic Apoliprotein E-ε4/4 homozygotes: A replication study J Neurol Sci 2001,189:93-98 10.1016/ S0022-510X(01)00577-9 11535238
59. Rubinsztein DC Easton DF Apolipoprotein E genetic variation and Alzheimer's disease: A meta-analysis Dem Ger Cogn Dis 1999, 10:199-209 10.1159/000017120
60. Borroni B Archetti S Agosti C Akkawi N Brambilla C Caimi L Caltagirone C DiLuca M Padovani A Intronic CYP46 polymorphism along with APOE genotype in sporadic Alzheimer Disease: From risk factors to disease modulators Neurobiol Aging 2005, 25:747-751 10.1016/j.neurobiolaging.2003.08.004